Precigen (PGEN) Net Margin Growth (3y) (2015 - 2025)
Precigen (PGEN) Net Margin Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
49,253.00 |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
506.00 |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Precigen |
1.32 Bn |
1.32 Bn |
20.69 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2025 |
-7.86 Mn |
| Mar 31, 2025 |
-412,255.00 |
| Dec 31, 2024 |
-134,700.00 |
| Sep 30, 2024 |
-260,296.00 |
| Jun 30, 2024 |
-902,124.00 |
| Mar 31, 2024 |
-1.72 Mn |
| Sep 30, 2022 |
545,491.00 |
| Jun 30, 2022 |
30,956.00 |
| Mar 31, 2022 |
12,519.00 |
| Dec 31, 2021 |
48,744.00 |
| Sep 30, 2021 |
9,210.00 |
| Jun 30, 2021 |
44,167.00 |
| Mar 31, 2021 |
14,605.00 |
| Dec 31, 2020 |
-4,974.00 |
| Sep 30, 2020 |
8,038.00 |
| Jun 30, 2020 |
-5,474.00 |
| Mar 31, 2020 |
-5,730.00 |
| Dec 31, 2019 |
-68,545.00 |
| Sep 30, 2019 |
3,624.00 |
| Jun 30, 2019 |
7,512.00 |
